five

Elsevier Author Aid Human Diseases Collection, part 2 (Monogenic Rare Diseases)

收藏
NIAID Data Ecosystem2026-05-02 收录
下载链接:
https://elsevier.digitalcommonsdata.com/datasets/8py7y8vvtb
下载链接
链接失效反馈
官方服务:
资源简介:
-----> Human Disease Author Aid Collection combines information about rare and common diseases in standardized, easy-to-navigate overview templates and tables. It includes clinical, molecular, and pharmacological data from several Elsevier's and public sources. Tables are planned to be updated quarterly. -----> Author Aid Templates can be a helpful guide for authors, researchers, clinicians, and students, especially those interested in rare diseases, because it highlights updates and findings from several sources on one page. -----> Each disease template overview includes 6 sections: Terminology; Epidemiology/Demographics; Clinical presentation/Diagnosis; Etiology/Pathology (genetics, biomarkers, pathways); Treatment/Follow-Up; Case studies. Each subset of data is linked to a list of publications with relevant citations. -----> Monogenic Rare Diseases (Human Disease Author Aid Collection, Part 2) In the current part, monogenic rare diseases were chosen based on their classification, prevalence, and degree of data availability. By "monogenic" we mean diseases that are caused by one or few known mutations. We considered worldwide point prevalence between <1/10 or 100 thousand (worldwide) as a criterion for filtering most significant rare diseases. Contents A) Curated templates about monogenic rare diseases: • Achondroplasia • Facioscapulohumeral dystrophy • Familial Mediterranean fever • Hereditary breast and ovarian cancer syndrome • Huntington disease • Congenital hypothyroidism • Rett syndrome • Usher syndrome • Wilson’s disease • Wiskott-Aldrich syndrome B) Automatically collected information about additional 21 Rare monogenic diseases. -----> PLEASE download files to read them and open the links!
创建时间:
2024-05-28
5,000+
优质数据集
54 个
任务类型
进入经典数据集
二维码
社区交流群

面向社区/商业的数据集话题

二维码
科研交流群

面向高校/科研机构的开源数据集话题

数据驱动未来

携手共赢发展

商业合作